Discounted Cash Flow (DCF) Analysis Levered
Streamline Health Solutions, Inc. (STRM)
$1.55
+0.05 (+3.33%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Actual | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected | 2028 Projected |
| Revenue | 22.36 | 20.74 | 11.35 | 17.38 | 24.89 | 27.62 | 30.64 | 34 | 37.73 | 41.86 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | 1.40 | -0.01 | -5.76 | -3.50 | -7.14 | -5.16 | -5.72 | -6.35 | -7.05 | -7.82 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -3.02 | -3.41 | -1.83 | -1.50 | -1.94 | -3.45 | -3.83 | -4.25 | -4.71 | -5.23 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -1.63 | -3.42 | -7.58 | -5 | -9.08 | -8.61 | -9.55 | -10.60 | -11.76 | -13.05 |
Weighted Average Cost Of Capital
| Share price | $ 1.55 |
|---|---|
| Beta | 1.287 |
| Diluted Shares Outstanding | 49.32 |
| Cost of Debt | |
| Tax Rate | -0.63 |
| After-tax Cost of Debt | 95.41% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 9.685 |
| Total Debt | 0.79 |
| Total Equity | 76.45 |
| Total Capital | 77.24 |
| Debt Weighting | 1.02 |
| Equity Weighting | 98.98 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Actual | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected | 2028 Projected |
| Revenue | 22.36 | 20.74 | 11.35 | 17.38 | 24.89 | 27.62 | 30.64 | 34 | 37.73 | 41.86 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.40 | -0.01 | -5.76 | -3.50 | -7.14 | -5.16 | -5.72 | -6.35 | -7.05 | -7.82 |
| Capital Expenditure | -3.02 | -3.41 | -1.83 | -1.50 | -1.94 | -3.45 | -3.83 | -4.25 | -4.71 | -5.23 |
| Free Cash Flow | -1.63 | -3.42 | -7.58 | -5 | -9.08 | -8.61 | -9.55 | -10.60 | -11.76 | -13.05 |
| WACC | ||||||||||
| PV LFCF | -7.79 | -7.81 | -7.84 | -7.87 | -7.90 | |||||
| SUM PV LFCF | -39.21 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 10.56 |
| Free cash flow (t + 1) | -13.31 |
| Terminal Value | -155.49 |
| Present Value of Terminal Value | -94.13 |
Intrinsic Value
| Enterprise Value | -133.34 |
|---|---|
| Net Debt | -5.81 |
| Equity Value | -127.53 |
| Shares Outstanding | 49.32 |
| Equity Value Per Share | -2.59 |